The UP421 The UP421 trial represents a pioneering Phase I study involving human participants, which is evaluating a novel immune-evasive...

RGB-5088 is a novel treatment for Type 1 Diabetes currently under investigation. This innovative therapy focuses on islet cell...

Lantidra is the first FDA-approved allogeneic pancreatic islet cellular therapy designed for adults with type 1 diabetes (T1D) who...

Type 1 diabetes (T1D) is a life-altering autoimmune condition where the immune system destroys insulin-producing beta cells in the...

When we think about managing blood glucose, the spotlight often shines on carbohydrates. While it’s true that carbs have the most direct...

May, 2024 The glycemic index (GI) is a measure of how quickly a carbohydrate-containing food raises blood sugar levels after...